Abstract
In-stent Restenosis (ISR) after stent implantation remains a frequent problem in coronary interventional therapy. Although Drug-Eluting Stent (DES) significantly reduces the rates of restenosis and Target Lesion Revascularization (TLR), the increasing use of DES in complex patients and lesions with
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
